Nilestriol
Nilestriol is a estriol derivative, which inhibits osteoporosis on ovariectomized rats or postmenopausal women[1].
Product Specifications
CAS Number
39791-20-3
Product Name Alternative
Nylestriol; EE3CPE
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/nilestriol.html
Concentration
10mM
Purity
99.83
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : 10 mg/mL (ultrasonic)
Smiles
C#C[C@]1(O)[C@H](O)C[C@@]2([H])[C@]3([H])CCC4=C(C=CC(OC5CCCC5)=C4)[C@@]3([H])CC[C@]12C
Molecular Formula
C25H32O3
Molecular Weight
380.52
Precautions
H302, H315, H319, H335
References & Citations
[1]Liao EY, et al., The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis. Endocr Res. 2003 May;29 (2) :217-26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882197-100 1x 100 µL
HCG-beta (Pregnancy & Choriocarcinoma Marker) (rHCGb/54), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details